Back to Deep Tech Week 2020
Whether you are a start-up, an incubator, an investor or a researcher, the Hello Tomorrow Global Summit is the place to get the best out of the Deep Tech ecosystem. Due to the health context, this edition will be fully hosted online, from 16th to 20th November 2020. This huge event gathers all the key players of innovation and is the best place to:
- Learn from other experts in their field
- Get connected within the deep tech ecosystem
- Boost your knowledge on innovation/entrepreneurship
- Scout future investment opportunities
Learn more about the program of Hello Tomorrow Global Summit 2020
Deep Tech Week 2020: a look back at the conference organized by Institut Curie
March 2020 saw the first edition of Deep Tech Week, a week to co-construct the technological solutions of tomorrow:, organized by Bpifrance, BCG, EPFL, Hello Tomorrow and SOSV. Institut Curie participated through the sponsorship of Carnot Curie Cancer, Carnot FINDMED and PSL University. With the current context surrounding the covid-19 pandemic, the 2nd part of Deep Tech Week has been postponed to autumn 2021. The objective is to bring together the key stakeholders that are building, financing and developing the deep dech technologies born in laboratories, propelling them to the market so that they can benefit as many people as possible. The purpose of the event is to:
- Deepen everyone's knowledge of these emerging technology solutions
- Promote a dialogue around deep tech technologies and to reflect on their challenges
- Offer visibility to entrepreneurs, laboratories, startups, universities, research centers or support structures
- Create new collaborations in order to accelerate the development of these innovations
- Create new strategic sectors
On this occasion, Institut Curie shared its expertise, as a key player in technology transfer in oncology, during a conference: "From discovery to gold standard in oncology".
Based around four round tables, the intervention of Institut Curie collaborators defined the fundamentals of technology transfer in oncology and its many challenges. How to go from being a laboratory discovery to becoming a gold standard in oncology? From the birth of the innovative technology to its emergence on the market, including the first clinical trials and the many choices available to inventors who embark on this adventure, the conference addressed these points in four steps:
The place of tech transfer in France and abroad |
To define the place of technology transfer offices in the research ecosystem |
Tech transfer option : entrepreneurship or license ? |
To define the most relevant road for the tech transfer (license-out vs. entrepreneurship) of breakthrough innovation in oncology |
From discovery to early stage clinical trial |
To understand how and why a breakthrough technology with a limited benchmark is financed |
From innovation to gold standard |
To understand how a breakthrough technology can access the market and become a gold standard in oncology versus other market |